Page 2 - Largest Swedish (OMX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Mar 21, 2024

Discover large cap Swedish Pharmaceuticals & Biotech companies that are on the OMX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

124 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ATORX

Alligator Bioscience
kr0.97-3.5%36.7%kr641.5mkr2.30PS10.8xE58.6%n/a

FLUO

FluoGuide
kr50.40-6.7%-50.3%kr614.8mkr141.94PS949.1xE36.5%n/a

PRO

Promimic
kr31.00-0.6%98.7%kr578.4mn/aPS14.8xn/an/a

MOB

Moberg Pharma
kr20.0023.5%-28.4%kr559.2mkr23.00PB0.9xE47.6%n/a

CANTA

Cantargia
kr3.0111.8%-53.5%kr552.2mkr12.67PB3.3xE65.3%n/a

ENZY

Enzymatica
kr3.20-4.2%5.1%kr525.6mkr4.69PS10.3xE57.8%n/a

ORX

Orexo
kr14.64-4.3%-2.1%kr504.3mkr22.50PB8.6xE75.1%n/a

INIT

Initiator Pharma
kr8.985.6%50.2%kr503.3mkr24.69PB29.4xE43.4%n/a

ONCO

Oncopeptides
kr4.479.7%-59.6%kr422.6mkr6.80PS12xE40.0%n/a

KDEV

Karolinska Development
kr1.50-4.0%-14.2%kr405.3mn/aPE75.2xn/an/a

IMMU

Mendus
kr0.472.5%-67.1%kr404.4mkr1.80PS13.7xE61.5%n/a

ACE

Ascelia Pharma
kr9.859.2%-38.7%kr332.5mkr9.75PB4.5xE4.4%n/a

CURAS

Curasight
kr.10.90-12.4%-29.9%kr.216.8mkr.29.00PB6.9xS149.8%n/a

HAMLET B

Hamlet BioPharma
kr1.91-7.3%-49.9%kr320.4mn/aPS134.8xn/an/a

MVIR

Medivir
kr2.83-0.3%-63.8%kr316.6mkr20.55PS41.7xE37.2%n/a

MAGLE

Magle Chemoswed Holding
kr28.802.9%6.7%kr311.0mkr40.00PE25.6xE41.2%1.2%

IVACC

Intervacc
kr3.600%-61.4%kr272.7mkr8.00PS34xE32.2%n/a

CLBIO

Corline Biomedical
kr12.452.0%37.1%kr267.6mkr32.00PS7.5xS44.4%n/a

SYNACT

SynAct Pharma
kr6.896.0%-89.9%kr245.1mn/aPB1.4xE10.6%n/a

NICA

Nanologica
kr6.30-5.4%-30.9%kr227.7mkr12.00PS48.7xS64.3%n/a

BIOVIC B

Biovica International
kr2.5316.1%-69.2%kr212.7mkr15.00PS30.5xE83.0%n/a

SANION

Saniona
kr1.90-2.5%-69.6%kr211.4mkr6.00PS12.6xE45.1%n/a

ACTI

Active Biotech
kr0.560%-38.7%kr202.6mkr1.90PB6.6xE59.7%n/a

PMDS

PMD Device Solutions
kr9.70-10.2%n/akr202.2mkr18.00n/an/an/a
Page 2 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.